Works by Takatsuka, Yuichi

Results: 62
    1

    Phase II study of capecitabine and trastuzumab combination chemotherapy in patients with HER2 overexpressing metastatic breast cancers resistant to both anthracyclines and taxanes.

    Published in:
    Cancer Chemotherapy & Pharmacology, 2009, v. 64, n. 2, p. 361, doi. 10.1007/s00280-008-0882-8
    By:
    • Ishida, Takanori;
    • Kiba, Takayoshi;
    • Takeda, Motohiro;
    • Matsuyama, Kotone;
    • Teramukai, Satoshi;
    • Ishiwata, Ryota;
    • Masuda, Norikazu;
    • Takatsuka, Yuichi;
    • Noguchi, Shinzaburo;
    • Ishioka, Chikashi;
    • Fukushima, Masanori;
    • Ohuchi, Noriaki
    Publication type:
    Article
    2
    3

    Phase II Trial in Japan of Sequential Administration of Weekly Paclitaxel Followed by FEC as Neoadjuvant Chemotherapy for Locally Advanced Breast Cancer [KBCSG0206 Trial: Kinki Breast Cancer Study Group (KBCSG)].

    Published in:
    Oncology, 2010, v. 78, n. 5/6, p. 302, doi. 10.1159/000318169
    By:
    • Taguchi, Tetsuya;
    • Masuda, Norikazu;
    • Nakayama, Takahiro;
    • Motomura, Kazuyoshi;
    • Tsukamoto, Fumine;
    • Shimazu, Kenzo;
    • Nomura, Takashi;
    • Morimoto, Takashi;
    • Yamamoto, Hiroshi;
    • Wakita, Kazuyuki;
    • Nakano, Yoshiaki;
    • Yoneda, Kohri;
    • Inaji, Hideo;
    • Takatsuka, Yuichi;
    • Noguchi, Shinzaburo
    Publication type:
    Article
    4
    5
    6
    7

    Neutrophil-to-lymphocyte ratio at the end of treatment with CDK4/6 inhibitors is an independent prognostic factor for ER-positive HER2-negative advanced breast cancer.

    Published in:
    International Journal of Clinical Oncology, 2024, v. 29, n. 12, p. 1850, doi. 10.1007/s10147-024-02625-w
    By:
    • Mitsuyoshi, Ayumu;
    • Nagahashi, Masayuki;
    • Kanaoka, Haruka;
    • Oshiro, Aoi;
    • Togashi, Yusa;
    • Hattori, Akira;
    • Tsuchida, Junko;
    • Higuchi, Tomoko;
    • Nishimukai, Arisa;
    • Murase, Keiko;
    • Takatsuka, Yuichi;
    • Miyoshi, Yasuo
    Publication type:
    Article
    8
    9
    10

    A multicenter phase II study of TSU-68, a novel oral multiple tyrosine kinase inhibitor, in patients with metastatic breast cancer progressing despite prior treatment with an anthracycline-containing regimen and taxane.

    Published in:
    International Journal of Clinical Oncology, 2013, v. 18, n. 4, p. 590, doi. 10.1007/s10147-012-0421-9
    By:
    • Suzuki, Yasuhiro;
    • Saeki, Toshiaki;
    • Aogi, Kenjiro;
    • Toi, Masakazu;
    • Fujii, Hirofumi;
    • Inoue, Kenichi;
    • Watanabe, Toru;
    • Fujiwara, Yasuhiro;
    • Ito, Yoshinori;
    • Takatsuka, Yuichi;
    • Iwata, Hiroji;
    • Arioka, Hitoshi;
    • Tokuda, Yutaka
    Publication type:
    Article
    11
    12
    13
    14
    15

    Randomized phase II study of three doses of oral TAS-108 in postmenopausal patients with metastatic breast cancer.

    Published in:
    Cancer Science, 2012, v. 103, n. 9, p. 1708, doi. 10.1111/j.1349-7006.2012.02354.x
    By:
    • Inaji, Hideo;
    • Iwata, Hiroji;
    • Nakayama, Takahiro;
    • Yamamoto, Naohito;
    • Sato, Yasuyuki;
    • Tokuda, Yutaka;
    • Aogi, Kenjiro;
    • Saji, Shigehira;
    • Watanabe, Kenichi;
    • Saito, Tsuyoshi;
    • Yoshida, Masayuki;
    • Sato, Nobuaki;
    • Saeki, Toshiaki;
    • Takatsuka, Yuichi;
    • Kuranami, Masaru;
    • Yamashita, Hiroko;
    • Kikuchi, Atsushi;
    • Tabei, Toshio;
    • Ikeda, Tadashi;
    • Noguchi, Shinzaburo
    Publication type:
    Article
    16
    17
    18
    19
    20

    Independent prognostic impact of preoperative serum carcinoembryonic antigen and cancer antigen 15-3 levels for early breast cancer subtypes.

    Published in:
    World Journal of Surgical Oncology, 2018, v. 16, p. 1, doi. 10.1186/s12957-018-1325-6
    By:
    • Imamura, Michiko;
    • Morimoto, Takashi;
    • Nomura, Takashi;
    • Michishita, Shintaro;
    • Nishimukai, Arisa;
    • Higuchi, Tomoko;
    • Fujimoto, Yukie;
    • Miyagawa, Yoshimasa;
    • Kira, Ayako;
    • Murase, Keiko;
    • Araki, Kazuhiro;
    • Takatsuka, Yuichi;
    • Oh, Koshi;
    • Masai, Yoshikazu;
    • Akazawa, Kouhei;
    • Miyoshi, Yasuo
    Publication type:
    Article
    21
    22

    Significant Association Between Low Baseline Neutrophil-to-Lymphocyte Ratio and Improved Progression-free Survival of Patients With Locally Advanced or Metastatic Breast Cancer Treated With Eribulin But Not With Nab-Paclitaxel.

    Published in:
    2018
    By:
    • Yoshimasa Miyagawa;
    • Kazuhiro Araki;
    • Ayako Bun;
    • Hiromi Ozawa;
    • Yukie Fujimoto;
    • Tomoko Higuchi;
    • Arisa Nishimukai;
    • Ayako Kira;
    • Michiko Imamura;
    • Yuichi Takatsuka;
    • Yasuo Miyoshi;
    • Miyagawa, Yoshimasa;
    • Araki, Kazuhiro;
    • Bun, Ayako;
    • Ozawa, Hiromi;
    • Fujimoto, Yukie;
    • Higuchi, Tomoko;
    • Nishimukai, Arisa;
    • Kira, Ayako;
    • Imamura, Michiko
    Publication type:
    journal article
    23
    24
    25
    26

    A genome-wide association study identifies locus at 10q22 associated with clinical outcomes of adjuvant tamoxifen therapy for breast cancer patients in Japanese.

    Published in:
    Human Molecular Genetics, 2012, v. 21, n. 7, p. 1665, doi. 10.1093/hmg/ddr597
    By:
    • Kiyotani, Kazuma;
    • Mushiroda, Taisei;
    • Tsunoda, Tatsuhiko;
    • Morizono, Takashi;
    • Hosono, Naoya;
    • Kubo, Michiaki;
    • Tanigawara, Yusuke;
    • Imamura, Chiyo K.;
    • Flockhart, David A.;
    • Aki, Fuminori;
    • Hirata, Koichi;
    • Takatsuka, Yuichi;
    • Okazaki, Minoru;
    • Ohsumi, Shozo;
    • Yamakawa, Takashi;
    • Sasa, Mitsunori;
    • Nakamura, Yusuke;
    • Zembutsu, Hitoshi
    Publication type:
    Article
    27
    28
    29
    30

    Clinical utility of tumor-infiltrating lymphocyte evaluation by two different methods in breast cancer patients treated with neoadjuvant chemotherapy.

    Published in:
    Breast Cancer (13406868), 2025, v. 32, n. 2, p. 404, doi. 10.1007/s12282-025-01665-y
    By:
    • Nagahashi, Masayuki;
    • Ishikawa, Eri;
    • Nagai, Takahiro;
    • Kanaoka, Haruka;
    • Oshiro, Aoi;
    • Togashi, Yusa;
    • Hattori, Akira;
    • Tsuchida, Junko;
    • Higuchi, Tomoko;
    • Nishimukai, Arisa;
    • Murase, Keiko;
    • Takatsuka, Yuichi;
    • Kihara, Takako;
    • Ling, Yiwei;
    • Okuda, Shujiro;
    • Hirota, Seiichi;
    • Miyoshi, Yasuo
    Publication type:
    Article
    31

    A prospective analysis of two studies that used the 5-mm interval slices and 5-mm margin-free method for ipsilateral breast tumor recurrence after breast-conserving surgery without radiotherapy.

    Published in:
    Breast Cancer (13406868), 2023, v. 30, n. 1, p. 131, doi. 10.1007/s12282-022-01406-5
    By:
    • Ohsumi, Shozo;
    • Nishimura, Reiki;
    • Masuda, Norikazu;
    • Akashi-Tanaka, Sadako;
    • Suemasu, Kimito;
    • Yamauchi, Hideko;
    • Tokunaga, Eriko;
    • Ikeda, Tadashi;
    • Nishi, Tsunehiro;
    • Hayashi, Hiroto;
    • Iino, Yuichi;
    • Takatsuka, Yuichi;
    • Ohashi, Yasuo;
    • Inaji, Hideo
    Publication type:
    Article
    32
    33
    34

    Association of body mass index with risk of luminal A but not luminal B estrogen receptor-positive and HER2-negative breast cancer for postmenopausal Japanese women.

    Published in:
    Breast Cancer (13406868), 2015, v. 22, n. 4, p. 399, doi. 10.1007/s12282-013-0493-z
    By:
    • Miyagawa, Yoshimasa;
    • Miyake, Tomohiro;
    • Yanai, Ayako;
    • Murase, Keiko;
    • Imamura, Michiko;
    • Ichii, Shigetoshi;
    • Takatsuka, Yuichi;
    • Ito, Takashi;
    • Hirota, Seiichi;
    • Saito, Masaru;
    • Kotoura, Yoshinao;
    • Miyauchi, Keisuke;
    • Fujimoto, Yasuhisa;
    • Hatada, Takuya;
    • Sasa, Mitsunori;
    • Miyoshi, Yasuo
    Publication type:
    Article
    35

    C4.4A highly expressed in HER2-positive human breast cancers may indicate a good prognosis.

    Published in:
    Breast Cancer (13406868), 2015, v. 22, n. 4, p. 366, doi. 10.1007/s12282-013-0487-x
    By:
    • Miyake, Tomohiro;
    • Ito, Takashi;
    • Yanai, Ayako;
    • Inoue, Natsuko;
    • Miyagawa, Yoshimasa;
    • Murase, Keiko;
    • Imamura, Michiko;
    • Ichii, Shigetoshi;
    • Takatsuka, Yuichi;
    • Nishizaki, Tomoyuki;
    • Hirota, Seiichi;
    • Ohtsuka, Masahisa;
    • Yamamoto, Hirofumi;
    • Noguchi, Shinzaburo;
    • Miyoshi, Yasuo
    Publication type:
    Article
    36
    37
    38

    Biological characteristics of luminal subtypes in pre- and postmenopausal estrogen receptor-positive and HER2-negative breast cancers.

    Published in:
    Breast Cancer (13406868), 2014, v. 21, n. 1, p. 52, doi. 10.1007/s12282-012-0348-z
    By:
    • Murase, Keiko;
    • Yanai, Ayako;
    • Saito, Masaru;
    • Imamura, Michiko;
    • Miyagawa, Yoshimasa;
    • Takatsuka, Yuichi;
    • Inoue, Natsuko;
    • Ito, Takashi;
    • Hirota, Seiichi;
    • Sasa, Mitsunori;
    • Katagiri, Toyomasa;
    • Fujimoto, Yasuhisa;
    • Hatada, Takuya;
    • Ichii, Shigetoshi;
    • Nishizaki, Tomoyuki;
    • Tomita, Naohiro;
    • Miyoshi, Yasuo
    Publication type:
    Article
    39
    40
    41

    Interim analysis of a phase II trial of cyclophosphamide, epirubicin and 5-fluorouracil (CEF) followed by docetaxel as preoperative chemotherapy for early stage breast carcinoma.

    Published in:
    Breast Cancer (13406868), 2005, v. 12, n. 2, p. 99, doi. 10.2325/jbcs.12.99
    By:
    • Iwata, Hiroji;
    • Nakamura, Seigo;
    • Toi, Masakazu;
    • Shin, Eisei;
    • Masuda, Norikazu;
    • Ohno, Shinji;
    • Takatsuka, Yuichi;
    • Hisamatsu, Kazufumi;
    • Yamazaki, Kosuke;
    • Kusama, Mikihiro;
    • Kaise, Hiroshi;
    • Sato, Yasuyuki;
    • Kuroi, Katsumasa;
    • Akiyama, Futoshi;
    • Tsuda, Hitoshi;
    • Kurosumi, Masafumi
    Publication type:
    Article
    42
    43
    44
    45
    46
    47
    48
    49
    50